healthcare
IFC leads $24m Series B for India's Onsurity
The International Finance Corporation (IFC) has led a USD 24m Series B round for Indian employee healthcare insurance start-up Onsurity.
Deal focus: India’s IIFL plans hospital expansion
India’s IIFL Asset Management is taking its private equity business deeper into healthcare with Kauvery Hospitals. The plan is to double patient capacity and IPO within three years
Temasek, A91, Kae back $135m round for India's HealthKart
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.
Polaris buys Japan care home operator
Polaris Capital Group has agreed to acquire a majority stake in Social Inclu, a Tokyo-based operator of more than 150 group homes for people with disabilities. The size of the investment was not disclosed.
India's Motilal Oswal closes latest fund at $552m
The private equity arm of India’s Motilal Oswal Financial Services has closed its fourth flagship growth fund with INR 45bn (USD 552m) in commitments.
Tower Capital closes maiden SE Asia PE fund on $379m
Singapore’s Tower Capital Asia, which has historically invested on a deal-by-deal basis, has closed its debut blind pool private equity fund for Southeast Asia on USD 379m.
Bessemer closes latest global VC fund on $3.85b
US-based Bessemer Venture Partners, which is currently expanding a longstanding presence in India, has closed its latest global VC fund with USD 3.85m in commitments.
Quadria plans full exit through Concord Biotech's India IPO
Singapore-based healthcare specialist Quadria Capital is set for a full exit from pharmaceuticals industry supplier Concord Biotech via an India IPO.
CDH, Huaxing lead $120m Series B for China’s InnoRNA
CDH Investments and Huaxing Healthcare Fund have led a USD 120m Series B for InnoRNA, a China-based mRNA drug developer. Existing investors CPE and Fangyuan Capital re-upped.
Huaxing Growth hits $800m second close on China fund
Huaxing Growth Capital, the private equity division of China Renaissance, has achieved a USD 800m second close on its fourth flagship US dollar-denominated fund.
China Renaissance hits first close on flagship US dollar fund
Huaxing Growth Capital, a new economy-focused private equity division of China Renaissance, has reached the first close on its fourth US dollar-denominated fund of $550 million.
CVC buys into Chinese pharmacy chain
CVC Capital Partners has made an investment of undisclosed size in Xi’an Yikang Pharmacy, China’s eighth-largest pharmacy chain.
Stellaris closes second India VC fund on $225m
Stellaris Venture Partners has closed its second early-stage India fund on $225 million, comfortably exceeding the $160 million target while diversifying the LP base.
Trustbridge leads $500m round for China's Dxy.cn
Trustbridge Partners has led a $500 million round for Dingxiangyuan – also known as dxy.cn – a Chinese digital medical platform that primarily serves as a forum for healthcare industry professionals.
Tata Growth commits $30m to India's Biocon
Tata Capital Growth Fund has invested INR2.25 billion ($30 million) in the biosimilars business of India-listed pharmaceuticals giant Biocon.
Advent to acquire Indian pharma player
Advent International has agreed to buy a controlling stake in Indian pharmaceutical company RA Chem Pharma.
B Capital closes second fund at $820m
B Capital Group, a US-based VC with a presence in Singapore and a significant Asia portfolio, has closed its second global fund at $820 million.
Indonesia's BRI Ventures launches fund
BRI Ventures, a unit of Bank Rakyat Indonesia, has launched a locally incorporated fund that will invest local start-ups.
CVC seeks control of India healthcare player HCG
CVC Capital Partners is looking to acquire majority control of Indian cancer care center operator HealthCare Global Enterprises (HCG) in a deal that could be worth up to IN10.4 billion ($$138.9 million).
Bessemer leads $20m Series B for India's DocsApp
Bessemer Venture Partners has led an INR1.5 billion ($20 million) Series B round for teleconsultation health platform DocsApp.
ADB Ventures raises $50m for debut fund
ADB Ventures, a VC unit of the Asian Development Bank launched earlier this year, is set to begin investment after raising $50 million for its debut impact fund.
ADB launches venture arm
The Asian Development Bank (ADB) has launched a VC arm focused on climate change-related technologies and women’s empowerment in the region.
MassMutual establishes second VC fund for Southeast Asia
US-based Massachusetts Mutual Life Insurance Company (MassMutual) has established a second venture capital fund for Southeast Asia with a corpus of $100 million.